Background Numerous hepatocellular carcinoma (HCC) biomarkers have been assessed in
the diagnosis and prognosis of HCC. The aim of this study was to assess the value of α …

Background In the present study we classified the radicality of percutaneous radiofrequency
thermal ablation (RFA) therapy according to the extent of the ablated margin. We measured …

Methods The subjects in this retrospective study comprised 102 patients with HCC who had
undergone RFA therapy and exhibited no recurrence of HCC 12 months thereafter. Serial …

Radiofrequency ablation (RFA), a new local therapy, has recently been developed for
hepatocellular carcinoma (HCC). In this study, we have checked for the factors influencing …

Background In Egypt, chronic hepatitis C virus (HCV) is the most prevalent cause of
hepatocellular carcinoma (HCC). The study aims to evaluate the percutaneous …

The increasing incidence of hepatocellular carcinoma (HCC) in Western countries requests
reliable tumour markers for preclinical diagnosis. We evaluated the diagnostic accuracy of …

Aim: to investigate whether plasma vascular endothelial growth factor (VEGF) and serum
Alpha-fetoprotein (AFP) could be used to predict short term response of hepatocellular …

Background Long-term survivals of patients with HBV-related hepatocellular carcinoma are
limited by the high incidence of tumor recurrence after radiofrequency ablation (RFA) …

Introduction: The aim of the study is to evaluate the role of alpha-fetoprotein (AFP) and des-
γcarboxy prothrombin (DCP) in the assessment of treatment response at one month in …

We analyzed how conditional survival (CS) after radiofrequency ablation (RFA) for early-
stage hepatocellular carcinoma (HCC) predicts survival estimates over time. We enrolled …